Cadonilimab Plus Platinum-Based Chemotherapy with or Without Bevacizumab As First-Line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer (COMPASSION-16): a Randomised, Double-Blind, Placebo-Controlled Phase 3 Trial in China Xiaohua Wu , Yang Sun , Hongying Yang , Jing Wang , Hanmei Lou , Dan Li , Ke Wang , Hui Zhang , Tao Wu , Yuzhi Li , Chunyan Wang , Guiling Li , Yifeng Wang , Dapeng Li , Ying Tang , Mei Pan , Hongyi Cai , Weihu Wang , Bing Yang , Hua Qian , Qiuhong Tian , Desheng Yao , Ying Cheng , Bing Wei , Xiumin Li , Tao Wang , Min Hao , Xiaohong Wang , Tiejun Wang , Juntao Ran , Hong Zhu , Lijing Zhu , Xianling Liu , Yunxia Li , Lihong Chen , Qingshan Li , Xiaojian Yan , Fei Wang , Hongbing Cai , Yunyan Zhang , Zhiqing Liang , Funan Liu , Yi Huang , Bairong Xia , Pengpeng Qu , Genhai Zhu , Youguo Chen , Kun Song , Meili Sun , Zhengzheng Chen , Qiang Zhou , Lina Hu , Guzhalinuer Abulizi , Hongyan Guo , Sihai Liao , Yijing Ye , Ping Yan , Qiu Tang , Guoping Sun , Ting Liu , Dongmei Lu , Mingxiu Hu , Zhongmin M. Wang , Baiyong Li , Michelle Xia LANCET（2024）
AI 理解论文
溯源树
样例
